L GLUTAMIC ACID
- Part number
- RXSOL-60-6604-824
- Category
- Medicine
- Brand
- RXSOL
Overview
Glutamic acid is an amino acid used to form proteins. In the body it turns into glutamate.
This is a chemical that helps nerve cells in the brain send and receive information from other cells.
Glutamic acid may be involved in learning and memory.
Applications
Glutamic acid often is used as a food additive and flavor enhancer in the form of its sodium salt, known as monosodium glutamate (MSG).
Dosage and directions
Glutamic acid is an amino acid used to form proteins. In the body it turns into glutamate. This is a chemical that helps nerve cells in the brain send and receive information from other cells. It may be involved in learning and memory.
Characteristics and notes
The relatively high glutamate levels in some traditional diets suggest that it is a safe food additive. However, anecdotal and scientific evidence indicates that high levels of glutamate and MSG consumption cause adverse health effects.
Safety and SDS
Read the safety data sheet before handling. Wear suitable gloves and eye protection.
View safety data sheet
| Product Name | L-GLUTAMIC ACID |
| Product Number | G8415 |
Company Details:
RX MARINE INTERNATIONAL
105, A wing , BSEL , TECH PARK.
VASHI ,NEW BOMBAY 400703 INDIA
Stock Point : UAE,OMAN,CANADA,INDIA,KENYA.
| Phone | +91 22 27815541 / 42 |
| Fax | +91 22 2781 1318 :::AOH :0091 9821214367 |
| rxsolchemicals@gmail.com |
| Formula | C5H9NO4 |
| Molecular weight | 147,13 g/mol |
| CAS-No. | 56-86-0 |
| EC-No. | 200-293-7 |
No components need to be disclosed according to the applicable regulations.
| Classification of the substance or mixture | Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. |
| Label elements | Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. |
| Other hazards |
This substance/mixture contains no components considered to be either persistent, bioaccumulative
and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
|
| If inhaled | After inhalation: fresh air. |
| Skin Contact |
In case of skin contact: Take off immediately all contaminated clothing. Rinse skin with
water/ shower.
|
| Eye Contact | After eye contact: rinse out with plenty of water. Remove contact lenses. |
| Swallowing |
After swallowing: make victim drink water (two glasses at most). Consult doctor if feeling
unwell.
|
| Ingestion: | Do not induce vomiting. Obtain medical attention.If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain an open airway and prevent aspiration. |
|
Most important symptoms and effects, both acute and delayed |
The most important known symptoms and effects are described in the labelling (see section
3) and/or in section 11
|
| ndication of any immediate medical attention and special treatment needed | No data available. |
| Suitable extinguishing media | Water Foam Carbon dioxide (CO2) Dry powder. |
| Unsuitable extinguishing media | For this substance/mixture no limitations of extinguishing agents are given. |
| Special hazards arising from the substance or mixture |
Carbon oxides
Sodium oxides
Combustible.
Development of hazardous combustion gases or vapours possible in the event of fire.
|
| Advice for firefighters | In the event of fire, wear self-contained breathing apparatus. |
| Further information | Suppress (knock down) gases/vapors/mists with a water spray jet. Prevent fire extinguishing water from contaminating surface water or the ground water system |
| Personal precautions, protectiveequipment and emergency procedures |
Advice for non-emergency personnel: Avoid inhalation of dusts. Evacuate the danger
area, observe emergency procedures, consult an expert.For personal protection see section 8.
|
|
Personal precautions,protective equipment and emergency procedures |
Advice for non-emergency personnel: Avoid inhalation of dusts. Evacuate the danger area, observe emergency procedures, consult an expert.For personal protection see section 8. |
| Environmental precautions | Do not let product enter drains. |
| Methods and materials for containment and cleaning up |
Cover drains. Collect, bind, and pump off spills. Observe possible material restrictions
(see sections 7 and 10). Take up dry. Dispose of properly. Clean up affected area. Avoid
generation of dusts.
|
| Reference to other sections | For disposal see section 13. |
| Precautions for safe handling | For precautions see section 3. |
|
Conditions for safe storage,including any incompatibilities |
Storage conditions
Tightly closed. Dry.
Storage class
Storage class (TRGS 510): 11: Combustible Solids
|
| Specific end use(s) | Apart from the uses mentioned in section 1.2 no other specific uses are stipulated |
| Explosive properties | No data available |
| Oxidizing properties | No data available |
| Control parameters | Ingredients with workplace control parameters |
| Personal protective equipment |
Eye/face protection
Use equipment for eye protection tested and approved under appropriate
government standards such as NIOSH (US) or EN 166(EU). Safety glasses
Skin protection
This recommendation applies only to the product stated in the safety data sheet,
supplied by us and for the designated use. When dissolving in or mixing with other
substances and under conditions deviating from those stated in EN374 please
contact the supplier of CE-approved gloves (e.g. KCL GmbH, D-36124 Eichenzell,
Internet: www.kcl.de).
Full contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
Material tested:KCL 741 Dermatril® L
This recommendation applies only to the product stated in the safety data sheet,
supplied by us and for the designated use. When dissolving in or mixing with other
substances and under conditions deviating from those stated in EN374 please
contact the supplier of CE-approved gloves (e.g. KCL GmbH, D-36124 Eichenzell,
Internet: www.kcl.de).
Splash contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
Material tested:KCL 741 Dermatril® L
Respiratory protection
required when dusts are generated.
Our recommendations on filtering respiratory protection are based on the following
standards: DIN EN 143, DIN 14387 and other accompanying standards relating to
the used respiratory protection system.
Recommended Filter type: Filter type P1
The entrepeneur has to ensure that maintenance, cleaning and testing of respiratory
protective devices are carried out according to the instructions of the producer.
These measures have to be properly documented.
Control of environmental exposure
Do not let product enter drains.
|
| Appearance | Powder. |
| Odour | No data available. |
| Odor Threshold | No data available. |
| pH | No data available. |
| Melting point/freezing point | Melting point/range: 205 °C. |
| Initial boiling point and boiling range | OECD Test Guideline 103decomposition below boiling point. |
| Flammability (solid, gas) | No data available. |
| Upper/lower flammability or explosive limits | No data available. |
| Vapor pressure | < 0,1 hPa at 20 °C - OECD Test Guideline 104. |
| Vapor density | No data available. |
| Density | 1,54 g/cm3 at 20 °C. |
| Relative density | No data available. |
| Water solubility | 8,64 g/l at 25 °C - soluble. |
|
Partition coefficient:
n-octanol/water
|
log Pow: < -4 at 20 °C - OECD Test Guideline 107 -
Bioaccumulation is not expected.
|
| Autoignition temperature | does not ignite. |
| Decomposition temperature | No data available. |
| Viscosity Viscosity, kinematic | No data available. |
| Viscosity, dynamic | No data available. |
| Explosive properties | No data available. |
| Oxidizing properties | None. |
| Other safety information | None. |
| Dissociation constant | Dissociation constant ca.9,36 at 20 °C- OECD Test Guideline 112. |
| Other safety information |
Surface tension: 74,2 mN/m at 1g/l at 20 °C - OECD Test Guideline 115. |
| Reactivity | The following applies in general to flammable organic substances and mixtures: in correspondingly fine distribution, when whirled up a dust explosion potential may generally be assumed. |
| Chemical stability | The product is chemically stable under standard ambient conditions (room temperature) . |
| Possibility of hazardous reactions |
Violent reactions possible with:
Strong oxidizing agents.
|
| Conditions to avoid | No data available. |
| Incompatible materials | No data available. |
| Hazardous decomposition products | In the event of fire: see section 5 |
| Acute toxicity |
LD50 Oral - Rat - male and female - > 5.110 mg/kg
Remarks: (ECHA)
Symptoms: Possible damages:, Nausea
Inhalation: No data available
Sigma- G8415 Page 6 of 9
The life science business of Merck operates as MilliporeSigma in
the US and Canada
LD50 Dermal - Rat - male and female - > 2.000 mg/kg
(OECD Test Guideline 402)
|
| Skin corrosion/irritation |
Skin - Rabbit
Result: No skin irritation - 4 h
(Regulation (EC) No. 440/2008, Annex, B.4).
|
| Serious eye damage/eye irritation |
Eyes - Rabbit
Result: No eye irritation
(Regulation (EC) No. 440/2008, Annex, B.5).
|
| Respiratory or skin sensitization |
Maximization Test - Guinea pig
Result: negative
(Regulation (EC) No. 440/2008, Annex, B.6).
|
| Germ cell mutagenicity |
Test Type: Ames test
Test system: Escherichia coli/Salmonella typhimurium
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Test Type: Micronucleus test
Species: Mouse
Cell type: Bone marrow
Application Route: Oral
Method: OECD Test Guideline 474
Result: negative.
|
| Carcinogenicity | No data available. |
| Reproductive toxicity | No data available. |
| Specific target organ toxicity - single exposure | No data available. |
| Specific target organ toxicity - repeated exposure | No data available. |
| Aspiration hazard | No data available. |
|
Endocrine disrupting properties
Product:
Assessment
|
The substance/mixture does not contain
components considered to have endocrine
disrupting properties according to REACH Article
57(f) or Commission Delegated regulation (EU)
2017/2100 or Commission Regulation (EU)
2018/605 at levels of 0.1% or higher.
To the best of our knowledge, the chemical, physical, and toxicological properties have not
been thoroughly investigated.Hazardous properties cannot be excluded but are unlikely
when the product is handled appropriately.This is a non-essential amino acid that occurs
in many forms in natural protein.Handle in accordance with good industrial hygiene and
safety practice.Hazardous properties cannot be excluded but are unlikely when the product
is handled appropriately.This is a non-essential amino acid that occurs in many forms in
natural protein.Handle in accordance with good industrial hygiene and safety practice.
|
| Toxicity to fish |
tatic test LC50 - Cyprinus carpio (Carp) - > 100 mg/l - 96 h
(OECD Test Guideline 203).
(ECHA)
|
|
Toxicity to daphnia
and other aquatic
invertebrates
|
static test EC50 - Daphnia magna (Water flea) - > 100 mg/l - 48 h
(OECD Test Guideline 202).
|
|
Toxicity to algae |
static test ErC50 - Pseudokirchneriella subcapitata (green algae) - >
31 mg/l - 72 h
(OECD Test Guideline 201).
|
| Biodegradability aerobic |
Exposure time 28 d
Result: 97 % - Readily biodegradable.
(OECD Test Guideline 301E).
Ratio BOD/ThBOD 64 %Ratio BOD/ThBOD 6 %Exposure time 42 d
Result: ca.99 % - Inherently biodegradable.
Remarks: (ECHA)
Chemical Oxygen
Demand (COD)
816 mg/g
Remarks: (IUCLID)
Ratio BOD/ThBOD 6 %
|
| Bioaccumulative potential | No data available. |
| Mobility in soil | No data available. |
| Results of PBT and vPvB assessment |
This substance/mixture contains no components considered to be either persistent,
bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at
levels of 0.1% or higher.
|
|
Endocrine disrupting properties
Product:
Assessment
|
The substance/mixture does not contain components
considered to have endocrine disrupting properties
according to REACH Article 57(f) or Commission
Delegated regulation (EU) 2017/2100 or Commission
Regulation (EU) 2018/605 at levels of 0.1% or higher.
12.7 Other adverse effects The substance/mixture does not contain components
considered to have endocrine disrupting properties
according to REACH Article 57(f) or Commission
Delegated regulation (EU) 2017/2100 or Commission
Regulation (EU) 2018/605 at levels of 0.1% or higher.
12.7 Other adverse effects
|
|
Other adverse effects
|
No data available. |
| Waste treatment Method | Product See www.retrologistik.com for processes regarding the return of chemicals and containers, or contact us there if you have further questions. |
| ADR/RID | ADR/RID | IMDG | IATA |
| UN number | - | - | - |
| UN proper shipping name | Not dangerous goods. | Not dangerous goods. | Not dangerous goods. |
| Transport hazard class(es) | - | - | - |
| Packaging group | - | - | - |
| Environmental hazards | No | No | No |
|
Safety Health and Environmenta
lregulations / legislation
specific for the substance or mixture
|
This material safety data sheet complies with the requirements of Regulation (EC) No.
1907/2006.
|
| Chemical Safety Assessment | For this product a chemical safety assessment was not carried out. |
| Other Information |
The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and weassume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no event shall be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if Rx Marine International has been advised of the possibility of such damages. DISCLAIMER OF LIABILITY :The information in this SDS was obtained from sources which we believe are reliable. However, the information is provided without any warranty, express or implied, regarding its correctness. The conditions or methods of handling, storage, use or disposal of the product are beyond our control and may be beyond our knowledge. For this and other reasons, we do not assume responsibility and expressly disclaim liability for loss, damage or expense arising out of or in any way connected with the handling, storage, use or disposal of the product. This MSDS was prepared and is to be used only for this product. If the product is used as a component in another product, this MSDS information may not be applicable. |
Availability
L GLUTAMIC ACID manufacturers, suppliers, exporters in Mumbai, Gandhidham, Kolkata, Varanasi, Visakhapatnam, Chennai, Fujairah, Dubai, Canada BC, Barka, Sohar, Muscat, Oman.
Lab chemicals manufacturers, suppliers, exporters in India, UAE Middle East, Barka, Sohar, Muscat, Oman, Canada.
L GLUTAMIC ACID is available in small packing as well as in bulk. Buy premium quality L GLUTAMIC ACID and other lab chemicals from one of the most trusted brands.
